Status: Recruiting
ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)
The purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery. Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications.
Participants needed: 100
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: University of Maryland St. Joseph Medical CenterUpdated: Dec 22, 2025Locations: 1
Eligibility criteria
Adult patients ≥ 18 years of age undergoing cardiac surgery requiring CPB [+4]
Bleeding as primary etiology of hypotension, as determined by > 4 units RBC tran... [+4]